The Ideal Customer Profile (ICP) document was written eighteen months ago. Marketing scores against it. Sales says it does not match the buyers who are actually closing. Both functions are working hard, hitting their respective metrics, and the pipeline keeps stalling on deals that should never have entered.
Sales and marketing ICP alignment is the single most expensive misalignment a B2B SaaS company carries between Series A and Series B, and almost every team treats it as a definitional problem when it is actually a measurement problem. The two teams are not failing to agree because they are stubborn. They are failing because they have never measured where, specifically, their working definitions of the ideal customer diverge.
The ICP Is Not One Thing, It Is Twelve Things
Most teams write an ICP document that defines company size, industry, geography, and a buyer persona. Then they assume the document is the ICP. It is not. The actual ICP that drives qualifying decisions inside the company includes twelve dimensions: company size, industry, geography, buyer persona, decision maker, technical environment, current solution being replaced, trigger event, sales cycle expectation, deal size band, success metric, and expansion potential.
Sales weights these dimensions one way, drawing on their experience with what closed last quarter. Marketing weights them another, drawing on what the campaign data and the original ICP exercise told them. Both functions believe they are using the same ICP. They are not, and the friction shows up as conflict on every lead, every deal, and every campaign brief.
The Symptom That Tells You the Gap Is Real
The clearest symptom that sales and marketing have ICP variance is the conversation that happens when an unexpected deal closes. Marketing celebrates a great close. Sales celebrates a great close. Then someone notices the deal does not match the documented ICP. Marketing says the lead source was unusual. Sales says the buyer was a perfect fit despite being outside the doc. Nobody updates the doc.
This conversation, repeated quarterly, is the visible signal that the formal ICP has decoupled from the working ICP each function actually uses. Until the variance is measured and resolved, the formal doc keeps drifting further from the reality of what closes.
Why Joint Planning Sessions Do Not Fix This
The standard response to ICP variance is to schedule a joint planning session. Sales and marketing leadership get in a room. They look at the win data, the lost data, and the pipeline. They debate. They produce a refreshed ICP doc that everyone signs off on. Three months later, the doc has been quietly ignored by both functions, who have returned to their respective working models.
Joint sessions fail because they produce alignment in the room and have no mechanism to enforce it after the room empties. The two functions go back to their independent dashboards, their independent metrics, and their independent intuitions about what makes a buyer real. Without continuous measurement of variance, the gap reopens at a predictable rate.
A Diagnostic Question to Bring to Your Next Sync
Ask your head of sales and your head of marketing to independently rank the twelve ICP dimensions in order of which one most predicts whether a deal will close. Do not let them coordinate. Compare the rankings.
If the top three dimensions on each list do not match, you do not have an ICP. You have two ICPs. The conversion rate, the win rate, and the sales cycle length are all reflecting that fact, even if no one has named it yet.
What Resolution Actually Looks Like
Resolving sales and marketing icp alignment is not a one-time event. It is a measurement system. The Diagnose assessment from GTM Alignment scores variance across all twelve ICP dimensions for $497 one time and returns a ranked report inside 24 hours. The report names the dimensions where the two functions disagree most about who the buyer is and what makes a deal closeable.
With the variance named and ranked, the leadership team can produce a working ICP that reflects what both functions actually believe, not just what the doc says. The new ICP is not the result of a debate. It is the result of a measurement that ended the debate.
Why This Compounds at Series B
The cost of unresolved ICP variance is not flat. It compounds. At Series A, with a small team and a hot market, the variance is a friction tax. At Series B, with a larger team and a colder market, the variance becomes the reason coverage ratios stay high while close rates collapse. By the time the company is fundraising again, the gap between the documented ICP and the working ICP is wide enough that diligence calls surface it as a strategy concern.
Catch it now. The Diagnose assessment is $497 one time and produces the variance score that the leadership team has been arguing about without data.
